Thomas Story & Son LLC Amgen Inc Transaction History
Thomas Story & Son LLC
- $237 Million
- Q1 2024
A detailed history of Thomas Story & Son LLC transactions in Amgen Inc stock. As of the latest transaction made, Thomas Story & Son LLC holds 1,325 shares of AMGN stock, worth $441,595. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,325
Previous 1,325
-0.0%
Holding current value
$441,595
Previous $382,000
1.31%
% of portfolio
0.16%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
2,984Shares Held
401MCall Options Held
6.59MPut Options Held
6.61M-
Vanguard Group Inc Valley Forge, PA52.1MShares$17.4 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$16 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.71 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.87 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.66 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $178B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...